Mitopharmacogenomics:
The Power of Mitochondria Over Your Medicine Cabinet
Did you
know that your mitochondrial DNA (mtDNA) can determine which drugs heal you and
which ones harm you?
MtDNA is the great forgotten player
in pharmacogenetics, but it can determine why a drug that saves lives in some
people becomes toxic in others!
Below you
will find how small changes in this genetic code shape your response to common
medications:
1.
Antibiotics: Breaking the Silence
Aminoglycosides
(AGs), such as gentamicin or neomycin, are antibiotics used to treat severe
bacterial infections. They act by inhibiting bacterial protein synthesis
through binding to the 30S ribosomal subunit. The m.1555A>G mutation,
located in the 12S rRNA gene, alters the human mitochondrial ribosome,
making it more similar to its bacterial counterpart and therefore susceptible
to aminoglycosides. The result is a toxic side effect: ototoxicity,
leading to hearing loss upon exposure to these drugs.
2.
Anesthesia and the Metabolic “Blackout”
Volatile
anesthetics and some neuromuscular blockers rely on mitochondria to sustain
energy production under physiological stress. Certain mtDNA variants can
increase sensitivity to volatile anesthetics, raising the risk of lactic
acidosis or organ dysfunction during surgery.
3.
Antiepileptic Drugs and Sudden Liver Failure
Valproic
acid (VPA) is a
widely used antiepileptic drug but has a well-known mitochondrial toxic
profile, as it inhibits β-oxidation. The liver, which is highly dependent on mitochondrial
function, is particularly vulnerable. Mutations in the gene encoding
mitochondrial DNA polymerase (POLG) reduce mtDNA copy number, severely
affecting energy-demanding tissues such as the liver and brain. In patients
carrying POLG mutations, VPA can be fatal due to hepatic
mitochondrial collapse.
4.
Antiretrovirals (HIV) and Chemotherapy: The Cost of Energy
Some HIV
treatments and certain chemotherapeutic agents directly impair mtDNA
replication. As a consequence of mitochondrial toxicity, patients
may develop extreme fatigue, muscle weakness (myopathy), and nerve
damage (neuropathy). In these cases, it is not only the disease—the
treatment itself contributes to the damage.




.png)


